Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Hydroxypyridine >  Deferiprone

Deferiprone

Basic information Safety Supplier Related

Deferiprone Basic information

Product Name:
Deferiprone
Synonyms:
  • L1
  • DMHP
  • DEFERIDONE
  • DEFERIPRON
  • DEFERIPRONE
  • CP20
  • 3-HYDROXY-1,2-DIMETHYL-4(1H)PYRIDINONE
  • 3-HYDROXY-1,2-DIMETHYL-4(1H)-PYRIDONE
CAS:
30652-11-0
MF:
C7H9NO2
MW:
139.15
EINECS:
212-783-8
Product Categories:
  • Heterocycles
  • API intermediates
  • Chelating Agents, Ligands
  • Chelating Agents & Ligands
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Building Blocks
  • Heterocyclic Building Blocks
  • Piperidones
Mol File:
30652-11-0.mol
More
Less

Deferiprone Chemical Properties

Melting point:
272-275 °C (lit.)
Boiling point:
255.1°C (rough estimate)
Density 
1.1997 (rough estimate)
refractive index 
1.4800 (estimate)
storage temp. 
2-8°C
solubility 
Soluble in Water (up to 5 mg/ml with warming).
form 
Crystalline Powder or Needles
pka
pKa1 3.3, pKa2 9.7(at 25℃)
color 
White to off-white
Water Solubility 
Soluble in hot water
Merck 
14,2859
Stability:
Stable for 1 year from date of purchase as supplied. Solutions are not stable and must be prepared fresh daily.
InChIKey
TZXKOCQBRNJULO-UHFFFAOYSA-N
CAS DataBase Reference
30652-11-0(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-36/37/38
Safety Statements 
26-36-37/39
WGK Germany 
3
RTECS 
UU7785940
HS Code 
29333990
Hazardous Substances Data
30652-11-0(Hazardous Substances Data)
Toxicity
LD50 i.p. in rats, mice: 650 mg/kg, 0.8-1.0 g/kg; i.g. in rats: 2.0-3.0 g/kg (Kontoghiorghes, 1995)

MSDS

More
Less

Deferiprone Usage And Synthesis

Description

Deferiprone is a lipophilic iron chelator that binds to iron at a molar ratio of 3:1 (ligand: iron). Its active form is available orally, making it the only oral iron chelator. Deferiprone is a member of the 4-pyridone family and is a pyridine 4-4 (1H) -one, with a methyl substitution at positions 1 and 2 and a hydroxyl substitution at position 3. By binding to iron, Deferiprone can remove excess iron from the body and prevent serum iron overload in patients with transfusion-dependent thalassemia. It has chelation and protective effects and is primarily used to treat thalassaemia.

Chemical Properties

White Needles

Originator

Cipla (India)

Uses

3-Hydroxy-1,2-dimethyl-4(1H)-pyridone (OH-pyridone) may be used in the bacterial killing assays. It has been employed as hydroxyketone chelating agent and its cytotoxic action against oral human normal and tumor cell lines has been evaluated.

Uses

A chelator that could replace disferrioxamine. It is orally and parenterally effective in the removal of iron in vivo from rabbits and mice and also from transferrin and ferritin in vitro

Definition

ChEBI: Deferiprone is a member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia. It has a role as an iron chelator and a protective agent.

brand name

Kelfer

General Description

3-Hydroxy-1,2-dimethyl-4(1H)-pyridone (Hdpp, Deferiprone) is a hydroxy ketone derivative. It reacts with uranyl salts [UO2(NO3)2] in aqueous acidic solution to afford mono nuclear complexes ([UO2(dpp)(Hdpp)2(H2O)]ClO4). X-ray studies have been conducted to examine the structure and geometry of these complexes.

Clinical Use

Orally administered chelator:
Treatment of transfusional iron overload

Metabolism

Deferiprone is hepatically metabolised to an inactive glucuronide metabolite and is excreted mainly in the urine as the metabolite and the iron-deferiprone complex, with a small amount of unchanged drug.

References

1) Hider and Hoffbrand (2018),?The Role of Deferiprone in Iron Chelation; N. Engl. J. Med.,?379?2140 2) Sripetchwandee?et al.?(2016),?A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloid-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload., Neuroscience?332?191 3) Liu?et al.?(2018),?Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications;?Front. Neurosci,?12?632

DeferiproneSupplier

He' nan ruisiqi new material co., ltd Gold
Tel
18903931628
Email
researchvip@163.com
Shandong Jihao Biotechnology Co., Ltd. Gold
Tel
0531-69958659 15668363232
Email
8598038@qq.com
Taizhou Creating Bio-pharm Co.,Ltd. Gold
Tel
+86-0576-88827176 +86-18906581668
Email
post@creatingchemical.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006608290; 18621169109
Email
market03@meryer.com